Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 4350712, 7 pages
http://dx.doi.org/10.1155/2016/4350712
Research Article

The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients

Di Xiao,1,2,3 Yu Guo,1,2,3 Xi Li,1,2,3 Ji-Ye Yin,1,2,3 Wei Zheng,1,2,3 Xin-Wen Qiu,4 Ling Xiao,1,2,3 Rang-Ru Liu,1,2,3 Sai-Ying Wang,1,2,3 Wei-Jing Gong,1,2,3 Hong-Hao Zhou,1,2,3 and Zhao-Qian Liu1,2,3

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China
3Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China
4Changsha Medical University Teaching Hospital, The People’s Hospital of Liuyang, Liuyang 410300, China

Received 29 September 2015; Revised 2 January 2016; Accepted 6 January 2016

Academic Editor: Franco Veglio

Copyright © 2016 Di Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Di Xiao, Yu Guo, Xi Li, et al., “The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients,” International Journal of Endocrinology, vol. 2016, Article ID 4350712, 7 pages, 2016. https://doi.org/10.1155/2016/4350712.